Viewing Study NCT01169558


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2025-12-25 @ 10:19 PM
Study NCT ID: NCT01169558
Status: COMPLETED
Last Update Posted: 2016-12-08
First Post: 2010-07-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.
Sponsor: Hoffmann-La Roche
Organization: